Lactiga Announces NIH-Funded Partnership with Mount Sinai

Oct 14, 2020 | Announcements

Lactiga announced today a collaboration agreement with the Icahn School of Medicine at Mount Sinai to advance preclinical research into LCTG-001 as a potential treatment for COVID-19 patients. The collaborative partners secured an NIH R01 Emergency Award of over $2MM to advance this study.

Lactiga featured in the Globe and Mail

Lactiga was featured in The Globe and Mail for its COVID-19 therapeutics program:

Lactiga featured in the Toronto Star

Lactiga’s R&D on milk antibodies against COVID-19 was featured in the Toronto Star, one of Canada’s largest newspapers: